Loading...
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
Toll-like receptors (TLRs) have first been characterized for their capacity to detect conserved microbial components like lipopolysaccharide (LPS) and double-stranded RNA, resulting in the elicitation of potent (innate) immune responses against invading pathogens. More recently, TLRs have also been...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3489745/ https://ncbi.nlm.nih.gov/pubmed/23162757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20931 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|